완화 케어 시장 - 예측(2026-2031년)

Palliative Care Market is expected to grow at a 7.29% CAGR, increasing to USD 23.581 billion in 2031 from USD 15.456 billion in 2025.

The palliative care market is a critical and expanding segment within the broader healthcare continuum, focused on improving the quality of life for patients facing serious, complex, and often life-limiting illnesses. Distinct from hospice care, palliative medicine is appropriate at any stage of a serious illness and can be provided alongside curative treatment. Its core mission is the relief of suffering through expert management of physical symptoms-such as pain, dyspnea, and nausea-coupled with the provision of psychosocial and spiritual support for both patients and their families. The market's growth is driven by the convergence of demographic trends, a shifting paradigm in healthcare delivery towards value and patient-centeredness, and increasing integration of palliative principles into standard medical practice.

A primary growth catalyst is the rising global prevalence of serious chronic illnesses and an aging population. As populations live longer, the burden of complex, progressive conditions like advanced cancer, heart failure, chronic obstructive pulmonary disease, and neurodegenerative diseases increases substantially. These conditions often involve significant symptom burdens and functional decline, creating a profound need for the specialized, holistic support that palliative care provides. This demographic and epidemiological reality establishes a large and growing patient population that benefits from palliative intervention, ensuring sustained demand for services.

Concurrently, the increasing awareness and acceptance of palliative care among patients, families, and healthcare professionals is a significant driver. Educational initiatives by advocacy organizations, professional societies, and healthcare institutions have progressively shifted perceptions, moving palliative care from a modality associated solely with the end of life to a recognized component of high-quality, comprehensive care for serious illness. There is greater understanding that early integration of palliative care can improve patient outcomes, enhance satisfaction, and in some cases, even extend survival. This cultural shift is reducing historical stigma and is encouraging earlier referrals and more open discussions about goals of care.

A major trend shaping the market is the active integration of palliative care into mainstream healthcare systems and policies. This is moving beyond standalone programs toward embedding palliative care principles and specialist teams within oncology, cardiology, neurology, and other specialty departments. Healthcare institutions are establishing inpatient consultation services, dedicated outpatient clinics, and embedded models within accountable care organizations. This integration is driven by evidence demonstrating that palliative care can reduce hospital readmissions, decrease unnecessary and aggressive care at the end of life, and improve care alignment with patient values-key metrics in value-based reimbursement models.

Aligned with patient preference and healthcare efficiency, there is a pronounced increase in demand for home-based palliative care services. Most patients express a desire to remain at home for as long as possible. Home-based models deliver interdisciplinary care-including nursing, physician oversight, social work, and therapy-directly to the patient, managing complex symptoms and providing support in a preferred, comfortable setting. This model has demonstrated significant potential to reduce emergency department visits and hospitalizations, making it economically favorable for payers while honoring patient autonomy. The growth of home health infrastructure and telehealth capabilities is further enabling this shift.

Geographically, Europe is often regarded as a leader in the development and integration of palliative care, supported by strong policy frameworks, government-led initiatives, and a high level of public awareness. Many European countries have national strategies for palliative care development and have worked to ensure its inclusion in universal health coverage. This established foundation fosters a more mature market with broader access compared to many other regions.

The service delivery model is inherently interdisciplinary, requiring collaboration between physicians, advanced practice providers, nurses, social workers, chaplains, and therapists. Services are delivered across multiple settings: inpatient hospital consultation teams, dedicated inpatient units, outpatient clinics, home-based programs, and within long-term care facilities. The variety of settings allows for a continuum of care that can adapt to changing patient needs and acuity levels.

The competitive landscape includes a diverse mix of providers: specialized palliative care organizations, large home health and hospice agencies that have expanded into palliative care, hospital and health system-based programs, and nonprofit entities. Success depends on the ability to demonstrate clear clinical value through improved patient-reported outcomes and reduced healthcare utilization, secure sustainable reimbursement through contracts with payers and health systems, and recruit and retain specialized clinical talent in a competitive field.

In conclusion, the palliative care market is evolving from a complementary service into an essential component of modern healthcare for serious illness. Its growth is structurally supported by demographic trends and the increasing complexity of chronic disease management. Future expansion will be shaped by the continued movement towards payment models that reward its value, successful scaling of home-based delivery, further penetration into non-cancer diagnoses, and ongoing efforts to build clinical capacity through training and education. The market's trajectory reflects a fundamental reorientation towards care that prioritizes quality of life, patient goals, and holistic support throughout the course of a serious illness.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Palliative Care Market Segmentation

• By Type
• Palliative Care At Homes
• Palliative Care in Care Center
• Palliative Care in Hospitals
• Inpatient Palliative Care
• By Application
• Cancer
• Cardiovascular Disease
• Neurological Disorder
• Chronic Kidney Disease
• Respiratory Disease
• Others
• By Age-Group
• Pediatric
• Adult
• Elderly
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Italy
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Taiwan
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. PALLIATIVE CARE MARKET BY TYPE

• 5.1. Introduction
• 5.2. Palliative Care At Homes
• 5.3. Palliative Care in Care Center
• 5.4. Palliative Care in Hospitals
• 5.5. Inpatient Palliative Care

6. PALLIATIVE CARE MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Cancer
• 6.3. Cardiovascular Disease
• 6.4. Neurological Disorder
• 6.5. Chronic Kidney Disease
• 6.6. Respiratory Disease
• 6.7. Others

7. PALLIATIVE CARE MARKET BY AGE-GROUP

• 7.1. Introduction
• 7.2. Pediatric
• 7.3. Adult
• 7.4. Elderly

8. PALLIATIVE CARE MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Age-Group
  • 8.2.4. By Country
    • 8.2.4.1. USA
    • 8.2.4.2. Canada
    • 8.2.4.3. Mexico
• 8.3. South America
  • 8.3.1. By Type
  • 8.3.2. By Application
  • 8.3.3. By Age-Group
  • 8.3.4. By Country
    • 8.3.4.1. Brazil
    • 8.3.4.2. Argentina
    • 8.3.4.3. Others
• 8.4. Europe
  • 8.4.1. By Type
  • 8.4.2. By Application
  • 8.4.3. By Age-Group
  • 8.4.4. By Country
    • 8.4.4.1. Germany
    • 8.4.4.2. France
    • 8.4.4.3. United Kingdom
    • 8.4.4.4. Spain
    • 8.4.4.5. Italy
    • 8.4.4.6. Others
• 8.5. Middle East and Africa
  • 8.5.1. By Type
  • 8.5.2. By Application
  • 8.5.3. By Age-Group
  • 8.5.4. By Country
    • 8.5.4.1. Saudi Arabia
    • 8.5.4.2. UAE
    • 8.5.4.3. Others
• 8.6. Asia Pacific
  • 8.6.1. By Type
  • 8.6.2. By Application
  • 8.6.3. By Age-Group
  • 8.6.4. By Country
    • 8.6.4.1. China
    • 8.6.4.2. India
    • 8.6.4.3. Japan
    • 8.6.4.4. South Korea
    • 8.6.4.5. Indonesia
    • 8.6.4.6. Thailand
    • 8.6.4.7. Taiwan
    • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Chemed Corporation
• 10.2. Humana Inc.
• 10.3. Gentiva
• 10.4. Amedisys, Inc.
• 10.5. AccentCare Inc.
• 10.6. Crossroads Hospice & Palliative Care
• 10.7. Caris Healthcare, L.P.
• 10.8. Compassus
• 10.9. Sunrise Senior Living (Revera)
• 10.10. Home Instead, Inc. (Honor Technology, Inc)

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations